ISSCR News
ISSCR Board Authors Commentary in Stem Cell Reports Responding to Flawed Study on Female Mentors and Mentees in Science
The ISSCR Board of Directors collaborated on a commentary published in Stem Cell Reports today titled, Mentorship in Science: Response to AlShebli et al., Nature Communications 2020. While the controversial paper, originally published in November 2020, was retracted on 21 December 2020, the message remains an important statement from the society and reinforces ISSCR's commitment to creating meaningful opportunities for women at all levels in their careers to thrive and succeed in stem cell science.
Member Spotlight: Lijian Hui, PhD
“I think the ISSCR provides me the largest platform to show our findings and it’s an international community where people share each other’s progress”.
The ISSCR Comments on EMA Draft Guidance on Registry-based Studies
The ISSCR recently delivered comments on the draft Guideline on Registry-based Studies (EMA/502388/2020). Among other points, the letter stated support the crucial role of the European Medicines Agency (EMA) in overseeing the development of safe and effective new products and the draft Guideline on Registry-based Studies. The Society also encouraged EMA to clarify the appropriate uses for patient registries to prevent them from being abused by businesses seeking to prematurely commercialize unproven stem cell-based interventions.
The ISSCR Shared Comments on Hong Kong's Draft Guidance for Cell and Tissue Products
The ISSCR recently offered comments on the draft Guidance for Cell and Tissue Products (those not classified as Advanced Therapy Products) with Assistant Director Frank Chan, Drug Office, Department of Health, Hong Kong.
The ISSCR Leads Coalition Letter to President-elect Biden on Human Fetal Tissue Research
The ISSCR and a coalition of 98 scientific, medical, and patient communities dedicated to advancing medical knowledge and improving human health urged President-elect Biden to swiftly rescind the human fetal tissue (HFT) research restrictions and policy changes that the Department of Health and Human Services made in 2019. Among other key points, the letter stated that these changes have halted all intramural HFT research and obstructed new extramural research involving HFT. Scientists and ethicists have repeatedly reviewed the use of HFT in research and have consistently concluded that HFT is an essential resource for biomedical research. HFT has led to many scientific and medical advances that have saved millions of lives. It remains critical for the development of new treatments for a wide range of serious diseases, including COVID-19.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .